Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

64 Cu-DOTA-Trastuzumab Positron Emission Tomography in Women With Advanced HER2 Positive Invasive Breast Cancer

NCT01093612 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01093612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01093612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
64 Cu-DOTA-Trastuzumab Positron Emission Tomography in Women With Advanced HER2 Positive Invasive Breast Cancer
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 16, 2011
Completion date
September 8, 2026
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, stage iv breast cancer